Transgene to Present Its Immuno-Oncology Expertise at Upcoming Scientific Conferences
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that
members of Transgene s management and scientific team have been invited to participate at upcoming (virtual) scientific conferences:
ESMO Targeted Anticancer Therapies Congress 2021 which will take place March 2-4:
Éric Quéméneur, Executive Vice President and Chief Scientific Officer (CSO), will be speaking in the session Where next with Oncolytics
about
Date Time: March 3
rd at 4.20pm (CET)
Royal Society Meeting on Immuno-oncology: How to get the immune system to beat cancer which will take place March 24-25: